drugset / Trial / NCT00160199
Safety and Efficacy of PROMETRIUM® Capsules in Induction of Secretory Conversion
RandomizedParallel-groupOpen-labelTreatment
Summary
To evaluate the efficacy and safety of 300 mg and 400 mg doses of PROMETRIUM® capsules in women of reproductive age with secondary amenorrhea
Timeline
- Start
- 2004-11
- Primary completion
- 2009-02
- Completion
- 2009-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Progesterone | Other / unclassified | 300 mg | Oral |
| Subject | Progesterone | Other / unclassified | 400 mg | Oral |